Learning objectives: Reading this article will familiarize the practitioner
with ongoing efforts to measure the effects of allergic rhinitis symptoms
and its treatments on the health-related quality of life (HRQOL) of patient
s. The reader will learn about instruments used to collect HRQOL data, resu
lts of studies showing the burden of illness and the effects of treatments
on HRQOL, and efforts to interpret the clinical relevance of changes in HRQ
OL status.
Data sources: Information was gleaned from articles listed in MEDLINE regar
ding HRQOL in allergic rhinitis between 1966 and 2000 (English language onl
y), and from the personal experiences of the authors.
Study selection: Questionnaire validation studies and representative contro
lled trials employing measures to assess the effects of allergic rhinitis s
ymptoms and its treatments on HRQOL are described.
Results from this Review: Allergic rhinitis symptoms can have detrimental e
ffects on the physical, psychologic, and social aspects of patients' lives.
Clinical trial data suggest a variety of pharmacologic therapies can signi
ficantly improve HRQOL in patients with allergic rhinitis. Validated questi
onnaires are now available that can easily be used in clinical practice to
measure the effects of interventions on HRQOL for individual patients.
Conclusions: Evaluating the effects of interventions on HRQOL may be partic
ularly important in a non-life-threatening condition such as rhinitis. Heal
th-related quality of life measures can be used to indicate the risk/benefi
t and the cost/benefit ratios of competing treatment options. Clinicians an
d policy makers are already using HRQOL data to evaluate results of medical
interventions to guide patient management and reimbursement decisions.